Rapid throughput DYNEX Technologies recently launched Agility Integra, a fully automated ELISA system designed for speed and precision. This presents a sales opportunity to laboratories facing rising test volumes and throughput demands, including pharmaceutical and biotech QA workflows.

Broad protocol ecosystem With over 1,000 established protocols and open platform compatibility across clinical assays, there is potential to upsell to labs seeking flexible, multi-disease testing on a single instrument, reducing platform fragmentation and enhancing workflow efficiency.

Strategic partnerships Recent collaboration with Tecan in the US indicates a market receptivity to channel and ecosystem partnerships, suggesting opportunities to expand distribution, co-marketing, or bundled offerings with complementary reagent and automation providers.

Global expansion signals Past facility expansions and innovation center investments in Europe point to ongoing international growth. This may open doors for entering or expanding in European hospitals and research labs with localized support and service packages.

Scale-ready solutions With ISO-certified, U.S.-manufactured instruments and a focus on scalable workflows adaptable to diverse sample types and lab-developed tests, there is value in offering scalable service, maintenance contracts, and training programs to mid-to-large labs aiming for long-term reliability.